# SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding

> **NCT01639768** · PHASE2 · COMPLETED · sponsor: **HAL Allergy** · enrollment: 270 (actual)

## Conditions studied

- Allergic Rhinitis
- Allergic Rhinoconjunctivitis

## Interventions

- **DRUG:** SUBLIVAC FIX Birch

## Key facts

- **NCT ID:** NCT01639768
- **Lead sponsor:** HAL Allergy
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-03
- **Final completion:** 2013-04
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2013-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01639768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01639768, "SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01639768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*